보고서 요약(국문)

개요
전 세계 대동맥 내 역박동 장치 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY억 달러에 이를 것으로 예상됩니다.
대동맥 내 역박동 장치는 심장이 혈액을 더욱 효율적으로 펌프질하도록 돕는 의료 기기입니다. 주로 심부전, 심인성 쇼크와 같은 심각한 심장 질환 관리 또는 특정 심장 시술 중에 사용됩니다. 이 장치는 심장에서 신체로 산소화된 혈액을 운반하는 주요 동맥인 대동맥의 혈류 타이밍을 조절하여 작동합니다.
대동맥 내 역박동 장치에는 여러 종류가 있지만, 대동맥 내 풍선 펌프와 대동맥 내 캐뉼라가 가장 널리 사용됩니다. 이러한 장치는 혈류와 관상동맥 관류를 개선하여 위중한 심장 질환에 매우 중요합니다.

시장 동향: 성장 동력
전 세계적으로 심장마비 발생률이 증가함에 따라 시장 성장이 촉진될 것으로 예상됩니다.
세계심장연맹(World Heart Federation)에 따르면 심혈관 질환(CVD)으로 인한 사망자 수는 1990년 1,210만 명에서 2021년 2,050만 명으로 급증했습니다. CVD는 심장과 혈관 질환을 총칭하는 용어로 관상동맥 질환, 뇌혈관 질환, 류마티스성 심장 질환 등을 포함합니다. CVD로 인한 사망의 80% 이상은 심장마비와 뇌졸중이며, 이 중 3분의 1은 70세 미만의 젊은 층에서 조기에 발생합니다.
심장 내 삽입형 심장 제세동기(IACD)는 심박출량을 증가시키고 관상동맥 혈류를 개선하여 급성 심장 질환 관리에 필수적인 역할을 합니다. 심장마비나 심각한 심부전과 같은 상황에서 IACD는 심장에 일시적인 부담을 줄여주고 주요 장기의 혈류 공급을 유지하는 데 도움을 줄 수 있습니다. 따라서 심혈관 질환(CVD) 관련 사망률 증가와 사례의 복잡성 증가로 인해 대동맥 내 역박동기(IACD)에 대한 수요가 증가하고 있습니다. 이 장치는 위급한 환자에게 생명줄이 될 수 있으며, 사망률을 낮추고 치료의 질을 향상시킬 수 있습니다.
결과적으로 의료 서비스 제공자들은 IACD의 생명 구조 잠재력을 점점 더 인식하고 치료 전략에 통합하고 있으며, 이는 IACD 시장 성장을 견인하고 있습니다. 또한 고령화 인구 증가와 고위험 심장 시술 건수 증가는 예측 기간 동안 시장 성장을 촉진할 것으로 예상되는 요인입니다.
시장 동향: 제약 요인:
대동맥 내 역박동기 시장은 제품 리콜, 높은 비용, 숙련된 시술자 부족 및 잠재적 합병증으로 인해 저해될 수 있습니다.
세분화 분석
전 세계 대동맥 내 역박동기 시장은 제품 유형, 수술 방법, 기술, 최종 사용자 및 지역별로 세분화됩니다.

제품 유형 부문에서 대동맥 내 풍선 펌프(IABP)는 혈액응고 분석기 시장 점유율의 약 47.8%를 차지했습니다.
대동맥 내 풍선 펌프(IABP)는 심장이 혈액을 보다 효율적으로 펌핑하도록 돕는 의료 기기입니다. 주로 심부전, 심인성 쇼크 또는 특정 심장 시술을 받는 환자와 같이 심각한 심장 질환 환자의 치료에 사용됩니다. 이 장치는 심장에서 신체의 나머지 부분으로 산소화된 혈액을 운반하는 주요 동맥인 대동맥 내 혈류 타이밍을 조절하여 작동합니다.
또한, 심혈관 질환의 유병률 증가와 고령 인구 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예상되는 요인입니다.
예를 들어, 2022년 심장학회지(Journal of Heart Association) 논문에 따르면, 특히 노년층에서 심혈관 질환의 전 세계적인 부담이 증가하고 있습니다. 이러한 인구 집단에서 가장 흔한 질환은 울혈성 심부전, 관상동맥 질환, 고혈압, 심방세동, 말초동맥 질환, 판막 심장 질환 및 뇌졸중입니다. 심혈관 질환을 앓는 노인들은 동반 질환과 노인 증후군으로 인해 복잡하고 심각한 상태를 보이며, 이는 기능 저하 및 합병증 발생 위험을 높입니다.
따라서 IABP(대동맥 내 풍선 펌프)는 진행성 심혈관 질환을 앓는 노인들에게 일시적인 심장 기능을 지원하는 데 필수적이며, 관상동맥 중재술이나 심장 수술과 같은 보다 확실한 치료로 이어지는 중요한 가교 역할을 합니다. 이러한 장치는 환자의 상태를 안정시키고, 최적의 상태를 유지하며, 수술 준비 상태를 향상시키는 데 도움을 줍니다.
또한, IABP는 심혈관 질환을 앓는 노인의 전반적인 예후를 크게 개선할 수 있습니다. 심장에 가해지는 부담을 줄이고 심박출량을 증가시킴으로써, 이러한 장치는 더 나은 결과를 가져오고 생존 가능성을 높입니다. 따라서 이러한 요인들로 인해 해당 시장 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

지리적 분석
북미 지역은 2022년 시장 점유율의 약 39.8%를 차지했습니다.
북미 지역은 심근경색 발병률 증가와 심장 수술 건수 증가로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 예를 들어, 흉부외과학회(STS)의 전국 성인 심장 수술 데이터베이스에 따르면 2021년에는 총 약 5,048건의 심장 수술이 시행되었습니다. 따라서 심장 수술 건수 증가로 인해 대동맥 내 역박동 장치(IACD)에 대한 수요가 증가할 것으로 예상됩니다.
반면, 제품 리콜은 시장에 부정적인 영향을 미치고 있습니다. 한 예로, 미국에서 Teleflex사가 Arrow AutoCAT 2 및 AC3 Optimus 대동맥 내 풍선 펌프에 대해 1급 리콜을 실시한 사례가 있습니다. 이 리콜은 모터 커넥터 배선의 잠재적 고장 때문이었습니다.

경쟁 환경
대동맥 내 역박동 장치 시장의 주요 글로벌 업체로는 Teleflex Incorporated, Getinge, Zeon Medical Inc., Abiomed, Inc. 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 심장 수술에 상당한 영향을 미쳤습니다. 많은 병원에서 COVID-19 환자 치료를 위해 응급 상황이 아닌 수술(심장 수술 포함)을 줄이거나 중단해야 했습니다. 이로 인해 수술 건수가 감소하고 수술 대기 환자 수가 늘어났습니다. 2021년 Archives of Cardiovascular Diseases에 발표된 논문에 따르면, 심장 수술은 수술 후 집중 치료가 필수적입니다. 이러한 전문 병동이 호흡기 지원이 필요한 COVID-19 환자 전용으로 사용되면서, 프랑스의 거의 모든 병원에서 선택적 개심 수술이 크게 지연되었습니다.
또한, 일부 심장 질환 환자는 기저 심장 질환으로 인해 COVID-19 감염 시 중증 질환 위험이 더 높을 수 있으며, 이로 인해 치료를 꺼릴 수 있습니다. 팬데믹으로 인해 심장마비로 병원에 입원하는 환자 수도 감소했는데, 이는 사람들이 코로나19 감염에 대한 두려움 때문에 의료기관 방문을 꺼렸기 때문으로 분석됩니다. 이로 인해 병원 수익이 감소했고, 심장 관련 서비스를 포함한 일부 서비스의 축소가 발생했습니다.
전반적으로 코로나19 팬데믹은 전 세계 심장 수술에 상당한 영향을 미쳐 수술 건수 감소, 수술 대기 환자 증가, 의료진 및 장비 부족, 병원 수익 감소 등을 초래했습니다.
보고서 구매 이유:

• 제품 유형, 적응증, 최종 사용자 및 지역별 글로벌 대동맥 내 역박동 장치 시장 세분화를 시각화하고 주요 상업 자산 및 업체들을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.
• 모든 세그먼트를 포함한 대동맥 내 역박동 장치 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트
• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서
• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일 제공
글로벌 대동맥 내 역박동 장치 시장 보고서는 약 43개의 표, 52개의 그림, 170페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global intra-aortic counterpulsation device market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
Intra-aortic counterpulsation device is a medical device designed to help the heart pump blood more effectively. It is mainly used to manage severe heart conditions, especially heart failure, cardiogenic shock, or during certain cardiac procedures. The device works by adjusting the timing of blood flow in the aorta the primary artery that carries oxygenated blood from the heart to the body.
There are various types of intra-aortic counterpulsation devices, but the intra-aortic balloon pump and intra-aortic cannula are the most popular. These devices are crucial in critical cardiac conditions as they improve blood flow and coronary artery perfusion.
Market Dynamics: Drivers
The increasing prevalence of heart attacks worldwide is expected to drive market growth
According to the World Heart Federation, deaths from cardiovascular disease (CVD) surged globally from 12.1 million in 1990 to 20.5 million in 2021. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. More than four out of five CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.
IACDs are essential in managing acute cardiac conditions as they help increase cardiac output and improve coronary blood flow. In scenarios like heart attacks or severe heart failure, IACDs can provide temporary relief to the heart, reducing strain, and supporting vital organ perfusion. Therefore, due to the rising prevalence of cardiovascular disease (CVD)-)-related fatalities and the increasing complexity of cases, there is a growing demand for IACDs. These devices can be a lifeline for patients in critical conditions, potentially reducing mortality rates and enhancing the quality of care.
As a result, healthcare providers are increasingly recognizing their lifesaving potential and incorporating them into their treatment strategies, which is driving growth in the IACD market. Furthermore, the growing aging population and an increasing number of high-risk cardiac procedures are the factors expected to drive the market over the forecast period.
Market Dynamics: Restraint:
The market for intra-aortic counterpulsation devices may be hindered by product recalls, high costs, shortage of skilled operators, and potential complications.
Segment Analysis
The global intra-aortic counterpulsation device market is segmented based on product type, surgical approach, technology, end-user and region.
The Intra-Aortic Balloon Pump (IABP) from the Product Type Segment Accounted for Approximately 47.8% of the Coagulation Analyzers Market Share
The Intra-Aortic Balloon Pump (IABP) is a medical device used to assist the heart in pumping blood more effectively. It is primarily employed in the management of patients with severe heart conditions, particularly those experiencing heart failure, cardiogenic shock, or undergoing certain cardiac procedures. The device operates by altering the timing of blood flow within the aorta, the main artery that carries oxygenated blood from the heart to the rest of the body.
Moreover, owing to the increasing prevalence of cardiovascular diseases, and the growing aging population are the factors expected to drive the market over the forecast period.
For instance, according to the Journal of Heart Association Article 2022, the global burden of cardiovascular disease is increasing, especially among older adults. The most common diseases in this demographic are congestive heart failure, coronary artery diseases, hypertension, atrial fibrillation, peripheral arterial disease, valvular heart disease, and stroke. Older adults with cardiovascular disease have complex and severe conditions due to comorbidities and geriatric syndromes, which puts them at higher risk of functional decline and complications.
Therefore, IABPs are essential in providing temporary support for older adults who suffer from advanced cardiovascular conditions, serving as a crucial bridge to more definitive treatments such as coronary interventions or cardiac surgeries. These devices help stabilize patients, optimize their condition, and improve their readiness for surgical procedures.
Moreover, IABPs can significantly improve the overall prognosis of older adults with cardiovascular disease. By reducing the workload on the heart and enhancing cardiac output, these devices contribute to better outcomes and increase the chances of survival. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.
Geographical Analysis
North America Accounted for Approximately 39.8% of the Market Share in 2022
North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of myocardial infarction, and growing cardiac surgeries. For instance, according to the Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database reported that in 2021, there were approximately 5,048 total cardiac surgeries performed. Therefore, there is an increase in demand for Intra-Aortic Counterpulsation Devices (IACDs) may increase due to the positive impact of the total number of cardiac surgeries.
In contrast, the market is being negatively affected by product recalls. One such example is the Class I level recall in the U.S. by Teleflex, which involved the Arrow AutoCAT 2 and AC3 Optimus intra-aortic balloon pumps. The recall was due to a potential breakdown of motor connector wires.
Competitive Landscape
The major global players in the intra-aortic counterpulsation device market include Teleflex Incorporated, Getinge, Zeon Medical Inc., and Abiomed, Inc. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant effect on cardiac surgery worldwide. Many hospitals have had to reduce or suspend non-emergency surgeries, including cardiac surgeries, to conserve resources for COVID-19 patients. This has reduced the number of surgeries performed and the backlog of patients waiting for surgery. As per the article published in the Archives of Cardiovascular Diseases in 2021, cardiac surgery systematically requires postoperative intensive care. As these specialized units were reserved for patients with COVID-19 necessitating respiratory support, elective open-heart surgeries were substantially delayed in almost all french centers.
Furthermore, some cardiac patients may be at a higher risk of severe illness from COVID-19 due to underlying heart conditions, which may make them more hesitant to seek treatment. The pandemic also decreased the number of patients admitted to hospitals for heart attacks, which is believed to be due to people being afraid to seek medical attention out of fear of getting COVID-19. This decreased hospital revenue, resulting in some downsizing of services, including cardiac services.
Overall, the COVID-19 pandemic has had a significant impact on cardiac surgery worldwide, leading to a decrease in the number of surgeries being performed and a backlog of patients waiting for surgery, as well as affecting the availability of medical staff and equipment and leading to a decrease in revenue for hospitals..
Why Purchase the Report?
• To visualize the global intra-aortic counterpulsation device market segmentation based on product type, indication, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of intra-aortic counterpulsation device market-level with all segments
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study
• Product mapping available as excel consisting of key products of all the major players
The global intra-aortic counterpulsation device market report would provide approximately 43 tables, 52 figures, and 170 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Indication
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of heart attacks worldwide
4.1.2. Restraints
4.1.2.1. Increasing product recalls
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Patent Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Intra-Aortic Balloon Pump (IABP)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Intra-Aortic Cannula
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Myocardial Infarction*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiogenic Shock
8.4. Heart Failure
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Heart Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Spain
10.3.6.5. Italy
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Teleflex Incorporated*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Getinge
12.3. Zeon Medical Inc.
12.4. Abiomed, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Teleflex Incorporated, 4. Key Developments, Getinge, Zeon Medical Inc., Abiomed, Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Intra-Aortic Counterpulsation Device Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Intra-Aortic Counterpulsation Device Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Intra-Aortic Counterpulsation Device Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 7 Global Intra-Aortic Counterpulsation Device Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 9 Global Intra-Aortic Counterpulsation Device Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 11 Global Intra-Aortic Counterpulsation Device Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Intra-Aortic Counterpulsation Device Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 14 North America Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 15 North America Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 16 North America Intra-Aortic Counterpulsation Device Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 18 South America Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 19 South America Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 20 South America Intra-Aortic Counterpulsation Device Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 Europe Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 23 Europe Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 24 Europe Intra-Aortic Counterpulsation Device Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Intra-Aortic Counterpulsation Device Market Value, By Product Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Intra-Aortic Counterpulsation Device Market Value, By Indication, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Intra-Aortic Counterpulsation Device Market Value, By End User, 2021-2030 (US$ Million)

Table 32 Teleflex Incorporated: Overview

Table 33 Teleflex Incorporated: Product Portfolio

Table 34 Teleflex Incorporated: Key Developments

Table 35 Getinge: Overview

Table 36 Getinge: Product Portfolio

Table 37 Getinge: Key Developments

Table 38 Zeon Medical Inc.: Overview

Table 39 Zeon Medical Inc.: Product Portfolio

Table 40 Zeon Medical Inc.: Key Developments

Table 41 Abiomed, Inc.: Overview

Table 42 Abiomed, Inc.: Product Portfolio

Table 43 Abiomed, Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 2 Global Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 4 Global Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 5 Global Intra-Aortic Counterpulsation Device Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Intra-Aortic Counterpulsation Device Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 7 Intra-Aortic Balloon Pump (IABP) Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 8 Intra-Aortic Cannula Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 9 Global Intra-Aortic Counterpulsation Device Market Y-o-Y Growth, By Indication, 2022-2030 (%)

Figure 10 Myocardial Infarction Indication in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 11 Cardiogenic Shock Indication in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 12 Heart Failure Indication in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 13 Others Indication in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 14 Global Intra-Aortic Counterpulsation Device Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 15 Hospitals End User in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 16 Ambulatory Surgical Centers End User in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 17 Specialty Heart Centers End User in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 18 Others End User in Global Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 19 Global Intra-Aortic Counterpulsation Device Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 20 North America Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 21 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 22 Europe Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 23 South America Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 24 Middle East and Africa Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 25 North America Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 26 North America Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 27 North America Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 28 North America Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 29 North America Intra-Aortic Counterpulsation Device Market Share, By Country, 2022 & 2030 (%)

Figure 30 South America Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 31 South America Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 32 South America Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 33 South America Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 34 South America Intra-Aortic Counterpulsation Device Market Share, By Country, 2022 & 2030 (%)

Figure 35 Europe Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 36 Europe Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 37 Europe Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 38 Europe Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 39 Europe Intra-Aortic Counterpulsation Device Market Share, By Country, 2022 & 2030 (%)

Figure 40 Asia-Pacific Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 41 Asia-Pacific Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 42 Asia-Pacific Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 43 Asia-Pacific Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 44 Asia-Pacific Intra-Aortic Counterpulsation Device Market Share, By Country, 2022 & 2030 (%)

Figure 45 Middle East & Africa Intra-Aortic Counterpulsation Device Market Value, 2021-2030 (US$ Million)

Figure 46 Middle East & Africa Intra-Aortic Counterpulsation Device Market Share, By Product Type, 2022 & 2030 (%)

Figure 47 Middle East & Africa Intra-Aortic Counterpulsation Device Market Share, By Indication, 2022 & 2030 (%)

Figure 48 Middle East & Africa Intra-Aortic Counterpulsation Device Market Share, By End User, 2022 & 2030 (%)

Figure 49 Teleflex Incorporated: Financials

Figure 50 Getinge: Financials

Figure 51 Zeon Medical Inc.: Financials

Figure 52 Abiomed, Inc.: Financials

글로벌 대동맥 내 역박동 장치 시장 – 2023-2030

Global Intra-Aortic Counterpulsation Device Market - 2023-2030